CTRI/2017/12/010795
Not yet recruiting
未知
â??Comparative 6 month clinical study of Modified Coronally Advanced Flap(MCAF) and Minimally Invasive Coronally Advanced Flap(MICAF) for the treatment of multiple adjacent gingival recession defectsâ??
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Patients with bilateral maxillary gingival recessions â?¥2mm classified as Millers class 1 in the esthetic zone of the oral cavity with gingival biotype â?¥1mm without any systemic complications
- Sponsor
- Manipal college of Dental Sciences Mangalore
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients who agree to participate in the study by signing the informed consent.
- •2\. Presence of bilateral maxillary gingival recessions \>\=2mm classified as Millers class 1 in the esthetic zone of the oral cavity with gingival biotype \>\=1mm.
- •3\. Difference in depth of the gingival recessions between the right \& left side \<\=1mm \& difference in clinical attachment \<\=2mm.
- •4\. Probing depth less than 3mm \& full mouth plaque score \<20%, full mouth gingival index score \<20%.
- •5\. Properly aligned teeth in the arch without any malposition
Exclusion Criteria
- •1\. Patients with systemically compromised health \& contraindicated for periodontal surgery.
- •2\. Periodontal surgical treatment during the previous 24 months on the involved sites.
- •3\. Current pregnancy or lactation.
- •4\. Patient with smoking habit.
- •5\. Patient with unjustified absence for scheduled visits, continued traumatic tooth brushing,faulty plaque control measures.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.EUCTR2007-001975-12-BEPIERRE FABRE MEDICAMENT - IDPF200
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairmentEUCTR2007-001975-12-FIPIERRE FABRE MEDICAMENT - IDPF210
Active, not recruiting
Phase 1
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Mild Cognitive ImpairmentMedDRA version: 9.1Level: LLTClassification code 10009846Term: Cognitive impairmentEUCTR2007-001975-12-FRPIERRE FABRE MEDICAMENT - IDPF200
Active, not recruiting
Phase 1
Evaluation of the effect of 6 months treatment with DC158AM on fatigue in patients with Parkinson’s disease. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.Fatigue symptoms in Parkinson's disease.MedDRA version: 9.1 Level: LLT Classification code 10013113 Term: Disease Parkinson'sEUCTR2007-002195-34-FRPIERRE FABRE MEDICAMENT120
Active, not recruiting
Not Applicable
Evaluation of the effect of 6 months treatment with V0191 on symptoms changes in patients with Mild Cognitive Impairment. Multicentre, randomised, double-blind, placebo-controlled study in parallel groups.EUCTR2007-001975-12-ATPIERRE FABRE MEDICAMENT - IDPF210